# Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

> **NCT01025635** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 401 (actual)

## Conditions studied

- Papulopustular Rosacea

## Interventions

- **DRUG:** Azelaic acid foam 15%
- **DRUG:** Vehicle foam

## Key facts

- **NCT ID:** NCT01025635
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 401 (ACTUAL)
- **Last updated:** 2020-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01025635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01025635, "Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01025635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*